PTC923, Kuvan 100 mg soluble tablets, PTC923
PTC923-PKU-301
Phase 3 small_molecule active
Quick answer
PTC923, Kuvan 100 mg soluble tablets, PTC923 for Phenylketonuria is a Phase 3 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Phenylketonuria
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active